AMA1-C1 malaria vaccine with Alhydrogel and CpG 7909

AMA1-C1 malaria vaccine adjuvanted with aluminum hydroxide (Alhydrogel) and CpG 7909 · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMA1-C1 malaria vaccine with Alhydrogel and CpG 7909, covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria [Phase 1]

See pricing